Myostatin levels vary according to SMA patient characteristics

External site

By following this link, you are leaving Medically and entering a website that is not owned or controlled by Roche. Roche does not take any responsibility for access to or use of this website, nor for any content therein.

Oct 12 / Springer Healthcare

Myostatin levels vary according to SMA patient characteristics

Neuroscience Spinal Muscular Atrophy WMS-2022

Description

Laurane Mackels discusses the results of a study showing that pretreatment levels of myostatin may be associated with disease type and motor function, and inversely correlated with age and weight, among people with spinal muscular atrophy.

Follow us here

This website is intended for healthcare professionals outside the United Kingdom (UK) and Australia. Registration status and prescribing information of medicinal products may differ between countries. Please refer to local product information for any medicinal products mentioned on this website.